Back
ManpowerGroup 10K Form
Buy
55
MAN
ManpowerGroup
Last Price:
75.56
Seasonality Move:
-1.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-03 | 10Q | MAN/ManpowerGroup Quarterly |
2023-08-04 | 10Q | MAN/ManpowerGroup Quarterly |
2023-05-05 | 10Q | MAN/ManpowerGroup Quarterly |
2022-11-07 | 10Q | MAN/ManpowerGroup Quarterly |
2022-08-05 | 10Q | MAN/ManpowerGroup Quarterly |
2022-05-06 | 10Q | MAN/ManpowerGroup Quarterly |
Receive MAN News And Ratings
See the #1 stock for the next 7 days that we like better than MAN
MAN Financial Statistics
Sales & Book Value
Annual Sales: | $18.91B |
---|---|
Cash Flow: | $104.2M |
Price / Cash Flow: | 14.32 |
Annual Sales: | $44.99 |
Price / Book: | 1.68 |
Profitability
EPS (TTM): | 0.97000 |
---|---|
Net Income (TTM): | $50.7M |
Gross Margin: | $3.36B |
Return on Equity: | 2.15% |
Return on Assets: | 0.58% |
ManpowerGroup Earnings Forecast
Key ManpowerGroup Financial Ratios
- The Gross Profit Margin over the past 34 years for MAN is 17.75%.
- The Selling, General & Administrative Expenses for MAN have been equal to 16.11% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 89.75% of Operating Income.
- The Net Earning history of MAN is 0.47% of Total Revenues.
- Per Share Earnings over the last 34 years have been positive in 22 years.
ManpowerGroup Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Professional Services |
Sector: | Industrials |
Current Symbol: | MAN |
CUSIP: | 56418H |
Website: | manpowergroup.com |
Debt
Debt-to-Equity Ratio: | 0.45 |
---|---|
Current Ratio: | 1.17 |
Quick Ratio: | 1.12 |
Price-to-Earnings
Trailing P/E Ratio: | 42.93 |
---|---|
Forward P/E Ratio: | 11.36 |
MAN Technical Analysis vs Fundamental Analysis
Buy
55
ManpowerGroup (MAN)
is a Buy
Is ManpowerGroup a Buy or a Sell?
-
ManpowerGroup stock is rated a Buy
The current ManpowerGroup [MAN] share price is $75.56. The Score for MAN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.